Literature DB >> 11015294

Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).

M C Olianas1, C Maullu, A Adem, E Mulugeta, E Karlsson, P Onali.   

Abstract

MT-7 (1 - 30 nM), a peptide toxin isolated from the venom of the green mamba Dendroaspis angusticeps and previously found to bind selectively to the muscarinic M(1) receptor, inhibited the acetylcholine (ACh)-stimulated [(35)S]-guanosine-5'-O-(3-thio)triphosphate ([(35)S]-GTPgammaS) binding to membranes of Chinese hamster ovary (CHO) cells stably expressing the cloned human muscarinic M(1) receptor subtype. MT-7 failed to affect the ACh-stimulated [(35)S]-GTPgammaS binding in membranes of CHO cells expressing either the M(2), M(3) or M(4) receptor subtype. In N1E-115 neuroblastoma cells endogenously expressing the M(1) and M(4) receptor subtypes, MT-7 (0.3 - 3.0 nM) inhibited the carbachol (CCh)-stimulated inositol phosphates accumulation, but failed to affect the CCh-induced inhibition of pituitary adenylate cyclase activating polypeptide (PACAP) 38-stimulated cyclic AMP accumulation. In both CHO/M(1) and N1E-115 cells the MT-7 inhibition consisted in a decrease of the maximal agonist effect with minimal changes in the agonist EC(50) value. In CHO/M(1) cell membranes, MT-7 (0.05 - 25 nM) reduced the specific binding of 0.05, 1.0 and 15 nM [(3)H]-N-methylscopolamine ([(3)H]-NMS) in a concentration-dependent manner, but failed to cause a complete displacement of the radioligand. Moreover, MT-7 (3 nM) decreased the dissociation rate of [(3)H]-NMS by about 5 fold. CHO/M(1) cell membranes preincubated with MT-7 (10 nM) and washed by centrifugation and resuspension did not recover control [(3)H]-NMS binding for at least 8 h at 30 degrees C. It is concluded that MT-7 acts as a selective noncompetitive antagonist of the muscarinic M(1) receptors by binding stably to an allosteric site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015294      PMCID: PMC1572361          DOI: 10.1038/sj.bjp.0703606

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  m2-toxin: A selective ligand for M2 muscarinic receptors.

Authors:  J M Carsi; H H Valentine; L T Potter
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

Review 2.  Adenylate cyclase assay.

Authors:  Y Salomon
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

3.  Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.

Authors:  M McKinney; D J Anderson; L Vella-Rountree; T Connolly; J H Miller
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

4.  Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.

Authors:  M C Olianas; A Ingianni; C Maullu; A Adem; E Karlsson; P Onali
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

5.  Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors.

Authors:  A Adem; A Asblom; G Johansson; P M Mbugua; E Karlsson
Journal:  Biochim Biophys Acta       Date:  1988-03-11

6.  Desensitization of muscarinic M1 receptors of murine neuroblastoma cells (clone N1E-115) without receptor down-regulation and protein kinase C activity.

Authors:  S Kanba; K S Kanba; M McKinney; M Pfenning; R Abraham; S Nomura; L Enloes; S Mackey; E Richelson
Journal:  Biochem Pharmacol       Date:  1990-09-01       Impact factor: 5.858

Review 7.  m1-toxin.

Authors:  L T Potter; H Hanchett-Valentine; J S Liang; S I Max; S L Purkerson; H A Silberberg; W L Strauss
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

8.  Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.

Authors:  J Nedoma; S Tucek; A F Danilov; S A Shelkovnikov
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

9.  Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4.

Authors:  S Lazareno; T Farries; N J Birdsall
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

10.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

View more
  17 in total

1.  Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

Authors:  Karen A Selz; Arnold J Mandell; Michael F Shlesinger; Vani Arcuragi; Michael J Owens
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

2.  Muscarinic acetylcholine receptor-mediated activation of G(q) in rat brain membranes determined by guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assay.

Authors:  Yuji Odagaki; Ryoichi Toyoshima
Journal:  J Neural Transm (Vienna)       Date:  2011-11-30       Impact factor: 3.575

3.  Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.

Authors:  H Kubista; K Kosenburger; P Mahlknecht; H Drobny; S Boehm
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

4.  Structure and selectivity engineering of the M1 muscarinic receptor toxin complex.

Authors:  Shoji Maeda; Jun Xu; Francois Marie N Kadji; Mary J Clark; Jiawei Zhao; Naotaka Tsutsumi; Junken Aoki; Roger K Sunahara; Asuka Inoue; K Christopher Garcia; Brian K Kobilka
Journal:  Science       Date:  2020-07-10       Impact factor: 47.728

5.  Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

6.  Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor.

Authors:  Catherine Marquer; Carole Fruchart-Gaillard; Guillaume Letellier; Elodie Marcon; Gilles Mourier; Sophie Zinn-Justin; André Ménez; Denis Servent; Bernard Gilquin
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

7.  Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors.

Authors:  Céline Rouget; Loïc Quinton; Arhamatoulaye Maïga; Céline Gales; Geoffrey Masuyer; Christian Malosse; Julia Chamot-Rooke; Robert Thai; Gilles Mourier; Edwin De Pauw; Nicolas Gilles; Denis Servent
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

8.  Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.

Authors:  C J Langmead; N E Austin; C L Branch; J T Brown; K A Buchanan; C H Davies; I T Forbes; V A H Fry; J J Hagan; H J Herdon; G A Jones; R Jeggo; J N C Kew; A Mazzali; R Melarange; N Patel; J Pardoe; A D Randall; C Roberts; A Roopun; K R Starr; A Teriakidis; M D Wood; M Whittington; Z Wu; J Watson
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

9.  Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels.

Authors:  Stefan G Lechner; Martina Mayer; Stefan Boehm
Journal:  J Physiol       Date:  2003-10-10       Impact factor: 5.182

10.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.